α-Glucosidase-IN-22 |
| Katalog-Nr.GC70181 |
α-Glucosidase-IN-22 (Verbindung 7i) ist ein Benzimidazol, ein wirksamer Inhibitor der α-Glucosidase mit einer IC50 von 0,64 μM. α-Glucosidase-IN-22 ist eine wirksame anti-diabetische Wirkstoffverbindung mit Potenzial für die Forschung zur Typ-2-Diabetes (T2DM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2870693-28-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for α-Glucosidase-IN-22
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for α-Glucosidase-IN-22
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *